Susan Moran - Dissemin

All papers authored by Susan Moran

This paper is made freely available by the publisher.

2023 Rachna T. Shroff

, Karyn A. Goodman

, Janice M. Mehnert, Julie M. Vose

, Susan E. Moran

, Jennifer L. Yessaian

, Lance Baldo

, Brian M. Alexander

, Quita B. Highsmith, Jennifer M. Mills, Pamela L. Kunz

Where Are All the Women in Industry Advisory Boards?

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2020 M. Teresa Magone

, Iris R. Hartley, Edmond Fitzgibbon, Rachel Bishop, Mike Arango, Susan Moran

, Roo Vold, Jaydira del Rivero

, Karen Pozo, Jamie Streit

, Kelly L. Roszko, Michael T. Collins, Rachel I. Gafni

Ocular Adverse Effects of Infigratinib, a New FGFR Tyrosine Kinase Inhibitor

Upload

Sumanta K. Pal

, Dean Bajorin, Nazli Dizman, Jean Hoffman-Censits, David I. Quinn, Daniel P. Petrylak, Matthew D. Galsky, Ulka Vaishampayan

, Ugo De Giorgi, Sumati Gupta, Howard A. Burris, Harris S. Soifer, Gary Li, Hao Wang, Carl L. Dambkowski and 3 other authors

Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results

Download from api.wiley.com

2019 S. Delaloge, D. Cella, Y. Ye, M. Buyse, A. Chan, C. H. Barrios, F. A. Holmes, J. Mansi, H. Iwata, B. Ejlertsen, B. Moy, S. K. L. Chia, M. Gnant, S. Smichkoska, A. Ciceniene and 13 other authors

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial

Download from academic.oup.com

Hope S. Rugo

, Jack A. Di Palma, Debu Tripathy, Richard Bryce, Susan Moran

, Elizabeth Olek, Linda Bosserman

The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea

Upload

2018 Kate R. Secombe

, Imogen A. Ball, Joseph Shirren, Anthony D. Wignall, John Finnie, Dorothy Keefe, Francesca Avogadri-Connors, Elizabeth Olek, David Martin, Susan Moran

, Joanne M. Bowen

Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model

Download from link.springer.com

2017 Miguel Martin, Frankie A. Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy, Hiroji Iwata, Gunter von Minckwitz, Stephen K. L. Chia, Janine Mansi, Carlos H. Barrios, Michael Gnant, Zorica Tomašević, Neelima Denduluri, Robert Šeparović, Erhan Gokmen and 607 other authors

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Upload

2015 Daniel P. Petrylak, Jitendra G. Gandhi, William R. Clark, Elisabeth Heath, Jianqing Lin, William K. Oh, David B. Agus, Bradley Carthon, Susan Moran

, Ning Kong, Ajit Suri, Michael Bargfrede, Glenn Liu

Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel–prednisone in metastatic castration-resistant prostate cancer

Download from link.springer.com

2014 Maha Hussain, Paul G. Corn, M. Dror Michaelson, M. D. Michaelson, Hans J. Hammers, Joshi J. Alumkal, Charles J. Ryan, Justine Y. Bruce, Susan Moran

, Shih-Yuan Lee, H. Mark Lin, Daniel J. George

Phase II Study of Single-Agent Orteronel (TAK-700) in Patients with Nonmetastatic Castration-Resistant Prostate Cancer and Rising Prostate-Specific Antigen

Download from aacrjournals.org

2012 A. J. Coles, E. Fox, A. Vladic, S. K. Gazda, V. Brinar, K. W. Selmaj, A. Skoromets, I. Stolyarov, A. Bass, H. Sullivan, D. H. Margolin, S. L. Lake, S. Moran

, J. Palmer, M. S. Smith and 1 other authors

Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial

Upload

2011 Alasdair J. Coles, Edward Fox, Anton Vladic, Suzanne K. Gazda, Vesna Brinar, Krzysztof W. Selmaj, Ann Doan-Do Bass, Daniel R. Wynn, David H. Margolin, Stephen L. Lake, Susan Moran

, Jeffrey Palmer, M. Shelton Smith, D. Alastair S. Compston

Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2008 H. Panitch, E. Anaissie, D. Cines, L. DeGroot, F. Dorsey, T. Phillips, J. Simon, Brinar, Demarin, D. Janculjak, J. Rudez, A. Vladic, A. Czlonkowska, D. Mirowska-Guzel, W. Kozubski and 80 other authors

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

Upload